Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) shares saw unusually-high trading volume on Friday . Approximately 106,022 shares changed hands during mid-day trading, an increase of 31% from the previous session’s volume of 80,695 shares.The stock last traded at $66.9675 and had previously closed at $66.26.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised shares of Lonza Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, April 8th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.
View Our Latest Report on Lonza Group
Lonza Group Stock Performance
About Lonza Group
Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.
The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.
Further Reading
- Five stocks we like better than Lonza Group
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
- Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
